{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:09:09Z","timestamp":1768568949037,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jaad.2009.04.048","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T04:58:50Z","timestamp":1258174730000},"page":"874-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Erythema multiforme during anti\u2013tumor necrosis factor treatment for plaque psoriasis"],"prefix":"10.1016","volume":"62","author":[{"given":"Jennifer","family":"Ahdout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Haley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin W.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.04.048_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1529-8019.2008.00180.x","article-title":"From conventional to cutting edge: the new era of biologics in treatment of psoriasis","volume":"21","author":"Tzu","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2009.04.048_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1468-3083.2006.01527.x","article-title":"Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments","volume":"20","author":"van de Kerkhof","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.04.048_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaad.2009.04.048_bib4","first-page":"1035","article-title":"Clinical use of anti-TNF-alpha biologic agents\u2014a guide for GPs","volume":"36","author":"Chang","year":"2007","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.jaad.2009.04.048_bib5","unstructured":"FDA Drug Safety Newsletter. U.S. Food and Drug Administration Web site. Available at: http:\/\/www.fda.gov\/cder\/dsn\/2008_winter\/toc.htm. Accessed January 10, 2009."},{"key":"10.1016\/j.jaad.2009.04.048_bib6","first-page":"850","article-title":"Erythema multiforme with tumor necrosis factor inhibitors: a class effect?","volume":"61","author":"Kain","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.04.048_bib7","first-page":"899","article-title":"Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis","volume":"67","author":"Soliotis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.04.048_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archderm.138.9.1258","article-title":"Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern","volume":"138","author":"Vergara","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.04.048_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.1983.tb01803.x","article-title":"Isomorphic phenomenon in erythema multiforme","volume":"8","author":"Huff","year":"1983","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.04.048_bib10","series-title":"Clinical dermatology","first-page":"627","article-title":"Erythema multiforme","author":"Habif","year":"2004"},{"key":"10.1016\/j.jaad.2009.04.048_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s004310051244","article-title":"Precipitants in 42 cases of erythema multiforme","volume":"158","author":"Villiger","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2009.04.048_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","article-title":"Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-\u03b3 is expressed in HAEM lesions and tumor necrosis factor-\u03b1 in drug induced erythema multiforme lesions","volume":"113","author":"Kokuba","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.04.048_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000018000","article-title":"Understanding the pathogenesis of HSV-associated erythema multiforme","volume":"19","author":"Aurelian","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.04.048_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archderm.144.7.902","article-title":"Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses","volume":"144","author":"Burnett","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.04.048_bib15","unstructured":"Humira (adalimumab) [package insert]. U.S. Food and Drug Administration Web site. Available at: http:\/\/www.fda.gov\/cder\/foi\/label\/2002\/adalabb123102LB.htm. Accessed January 10, 2009."},{"key":"10.1016\/j.jaad.2009.04.048_bib16","unstructured":"Enbrel (etanercept) [package insert]. U.S. Food and Drug Administration Website. Available at: http:\/\/www.fda.gov\/cder\/foi\/label\/2008\/103795s5359lbl.pdf. Accessed January 10, 2009."},{"key":"10.1016\/j.jaad.2009.04.048_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2133.2008.08851.x","article-title":"The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature","volume":"159","author":"Domm","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.04.048_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1752-1947-2-282","article-title":"Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving Infliximab: a case report","volume":"2","author":"Justice","year":"2008","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.jaad.2009.04.048_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000074112","article-title":"Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction","volume":"207","author":"Ng","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.04.048_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0536.1996.tb02277.x","article-title":"Natural rubber latex contact dermatitis with features of erythema multiforme","volume":"35","author":"Bourrain","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2009.04.048_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.0105-1873.2003.0225m.x","article-title":"Erythema multiforme with occupational rubber contact sensitivity","volume":"49","author":"Bara","year":"2003","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2009.04.048_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1600-0536.2001.450520.x","article-title":"Localized erythema-multiforme-like contact dermatitis from rubber gloves","volume":"45","author":"Lu","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2009.04.048_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatfall","year":"1995","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209005428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209005428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:16:01Z","timestamp":1759270561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209005428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0190962209005428"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.04.048","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythema multiforme during anti\u2013tumor necrosis factor treatment for plaque psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.04.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}